Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Brexit, Coronavirus, AstraZeneca

Sun, 13th Dec 2020 18:57

(Sharecast News) - Britain and the EU have taken a step forward towards striking a post-Brexit trade and security deal after Boris Johnson and Ursula von der Leyen agreed to "go the extra mile" and ordered the resumption of talks in Brussels. The prime minister played down expectations following the telephone conversation with the European commission president, telling the cabinet to prepare for a no-deal exit when the transition period ends in three weeks' time. But in Brussels, EU embassies were briefed by the commission that "progress has been made" and that "the next days will be important". - Guardian

Britain could be "back to normal" by summer as long as it avoids a third wave after Christmas, the British scientist behind a Covid vaccine has said. Professor Sarah Gilbert, the lead researcher on the Oxford vaccine, said "people's behaviour in the coming weeks is going to have a big impact" on when facemasks and social distancing requirements can be dropped. She said that a spike in coronavirus cases in January would disrupt vaccination programmes. - Sunday Times

Britain's biggest maker of pharmaceuticals has swooped on an American rival in a daring move on the eve of Brexit. Astra Zeneca, the FTSE 100 drug-maker playing a central role in the fight against Covid-19, has agreed to buy Alexion Pharmaceuticals for $39bn (£28.9bn). The cash-and-shares deal will cement the Anglo-Swedish giant's position in immunology and give it a dedicated rare disease business based in Boston, Massachusetts. - Sunday Times

Keith Williams is a man of many modes of transport. The corporate veteran spent 18 years at airline British Airways - the final five as chief executive and chairman - and will in the New Year publish his long-awaited review into the rail industry. Now he is the boss of Royal Mail - and drones are firmly on his radar. Williams wants to use the unmanned vehicles to fly letters to remote areas in the UK. 'If you take, say, the Scilly Isles - an expensive piece of water [to cross] - they might be ideally suited to a drone,' he says. - Mail on Sunday

More Leave voters than Remainers have swung from the Tories to Labour since the last election, according to a major polling project that suggests Keir Starmer, the Labour leader, has made some early progress in bridging the Brexit divide. A large 7,000-strong poll, designed to examine the political changes that have taken place since Labour's disastrous result, found that the party was showing signs of winning over some of those who backed the Tories last year. - Guardian

Giant American fashion and investment corporations are eyeing up bids for Topshop and its parent group Arcadia. [...] Around 30 to 40 potential buyers are believed to have shown initial interest and have received a limited information pack on the business from Arcadia's administrators, Deloitte. First-round bids are due in by the end of this week. - Mail on Sunday

A French satellite giant is muscling in on Britain's broadband market by targeting half a million people in the remotest parts of the nation. Eutelsat has launched Konnect, a satellite broadband service for homes that will not benefit from industry efforts to carpet Britain in gigabit speed connectivity. The service was rolled-out in the UK last week ahead of expanding across Europe and parts of Africa using the same satellite infrastructure. - Sunday Telegraph

Mike Ashley is racing to complete a deal to buy Debenhams this weekend, sources have told The Mail on Sunday. The sportswear mogul is in talks to buy the £500million web business - to help him crack the high-end cosmetics market - but the Debenhams store chain has been vastly slimmed down. 'There's very little time left to rescue the business,' said one City source. 'But without at least 30 or 40 of the 124Nightcap stores, this might not look very much like a rescue at all.' - Mail on Sunday

Dragons' Den entrepreneur Sarah Willingham is preparing to float a chain of city-centre bars with a team including celebrity chef Raymond Blanc, despite the malaise gripping leisure. Willingham, 46, has agreed a counterintuitive deal to buy London Cocktail Club through a stock market listing of her investment vehicle, Nightcap, on AIM in the coming weeks. She plans to raise £6m at a valuation of £14m. - Sunday Times



More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.